Please login to the form below

Not currently logged in

Merck & Co extends med ed portal to India

Pharma company makes Univadis accessible to yet more healthcare professionals
Merck Univadis India

India has become the latest in more than 40 countries to have access to Univadis, a healthcare education and information produced by Merck & Co.

The website, launched in 2001, is free to healthcare professionals and has been developed in conjunction with London-based medical publication The Lancet. It gives users access to exclusive content such as articles, news, research papers, videos and other educational tools.

"We are launching a unique online medical education service to aid comprehensive healthcare management, making available unbiased, reliable scientific medical information," said KG Ananthakrishnan, managing director of Merck's Indian subsidiary MSD Pharmaceuticals Pvt.

“This unique medical education service to support comprehensive healthcare management will provide Indian doctors with updated information to expand their knowledge and expertise”.

It is hoped that Merck's move will help health professions in India, where providing continued medical education for doctors remains challenging.

At present, Indian doctors' medical knowledge is either not updated frequently enough or they find themselves dependent on sponsored conferences for their ongoing education and access to news of industry developments.

“Our partnership with Univadis offers a unique opportunity to increase delivery of the best science to Indian doctors in free and easily accessible format,” added David Collingridge, publishing director for Lancet specialty journals.

Article by
Tara Craig

1st July 2014

From: Marketing



Featured jobs

Subscribe to our email news alerts


Add my company

At H4B, we are an energetic new team with fresh ideas, but we have over 275 years of combined experience...

Latest intelligence

Revisiting Instagram for pharma
In pharma, Instagram usage is increasing because it offers so many benefits to engage with patients and HCPs...
The one multichannel question you must ask
There is a question every marketer should ask when designing a multichannel communications strategy...
Medius Deal Watch
Deal Watch September 2016
Abbott, Allergan, Celgene, Moderna, Pfizer and Takeda feature in this month's pharma deals round-up...